RESMED INC (RMD)
RESMED INC (RMD) from its SEC filings: 2026 revenue $5.7 billion (+10% vs the year before), net margin 27%, free cash flow $1.6 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2026) | $5.7 billion |
| Revenue growth | +10% |
| Net income | $1.5 billion |
| Net margin | 26.9% |
| Free cash flow | $1.6 billion |
| Diluted EPS | $10.43 |
| Latest quarter (Q1 2026 (calendar)) revenue vs a year earlier | +11% |
| Cash | $1.5 billion |
| Long-term debt | $1.0 billion |
| Share count, 1 year | -2% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.